Table 3.
ORs of ≥ G2 fibrosis or fat necrosis for different polymorphisms and their combination
| Polymorphisms | Genotype | ≥ G2 fibrosis or fat necrosis |
OR (95% CI) |
p-value (*) | p-value (§) |
|---|---|---|---|---|---|
| XRCC1 (Arg399Gln) | AA | 45% | 1 | ||
| aa/Aa | 54% | 1.41 (0.44-4.58) | 0.514 | 0.599 | |
| XRCC3(A4541G) | aa/Aa | 44% | 1 | ||
| AA | 53% | 1.43 (0.45-4.71) | 0.494 | 0.596 | |
| XRCC3(C18067T) | AA/Aa | 51% | 1 | ||
| aa | 33% | 0.49 (0.04-3.75) | 0.413 | 0.670 | |
| GSTP1 | AA | 38% | 1 | ||
| aa/Aa | 64% | 2.9 (0.88-10.14) | 0.047 | 0.064 | |
| RAD51 | AA | 48% | 1 | ||
| aa/Aa | 67% | NA # | 0.9751 | 0.6115 | |
Abbreviations: (*) Chi-squared, (§) Fisher's exact Test, #: not applicable due to the limited number of events